<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01454050</url>
  </required_header>
  <id_info>
    <org_study_id>55</org_study_id>
    <nct_id>NCT01454050</nct_id>
  </id_info>
  <brief_title>Lumax 740 Master Study</brief_title>
  <acronym>Lumax 740</acronym>
  <official_title>PME/Master Study of the Lumax 740 ICD Family</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to prove the safety and efficacy of the Lumax 740 ICD family.
      Primarily, the newly implemented RV/LV Capture Control algorithm is evaluated, which
      automatically measures the RV/LV threshold and subsequently adjusts the pacing output.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of the automatic Capture Control feature</measure>
    <time_frame>PHD, 1-, 3- and 6-month follow-up</time_frame>
  </primary_outcome>
  <enrollment type="Actual">189</enrollment>
  <condition>Safety and Efficacy of the Lumax 740 ICD Family</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with standard ICD indication who are referred to the hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion Criteria: Standard indication for single, dual, or triple chamber ICD.

               -  Legal capacity and ability to consent

               -  Signed patient informed consent

        In addition for HF-T devices:

          -  Bipolar LV-lead with a min. distance of 15 mm between tip and ring

          -  True bipolar RV lead

        Exclusion Criteria:

          -  Standard contraindication for single, dual, or triple chamber ICD.

               -  Age &lt; 18 years

               -  Pregnant or breast-feeding woman

               -  Cardiac surgery planned within the next 6 months

               -  Life expectancy of less than 6 months

               -  Participating in any other clinical study of an investigational cardiac drug or
                  device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gunnar Klein, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Herz im Zentrum Hannover, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical School Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2011</study_first_submitted>
  <study_first_submitted_qc>October 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2011</study_first_posted>
  <last_update_submitted>November 27, 2012</last_update_submitted>
  <last_update_submitted_qc>November 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICD therapy</keyword>
  <keyword>RV/LV Capture Control</keyword>
  <keyword>Safety and Efficacy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

